Optimizing Lead Placement in Sacral Neuromodulation

被引:4
作者
Couvaras, Anastasia [1 ]
Goudelocke, Colin [1 ]
机构
[1] Ochsner Hlth, 1004 Octavia St, New Orleans, LA 70115 USA
关键词
Sacral neuromodulation; Lead optimization; Overactive bladder; Fecal incontinence; Non-obstructive urinary retention; LONG-TERM EFFICACY; NERVE-STIMULATION; 2-STAGE IMPLANTATION; URGE INCONTINENCE; MULTICENTER; MOTOR; OUTCOMES; THERAPY; SUCCESS; IMPACT;
D O I
10.1007/s11884-021-00634-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Sacral neuromodulation remains an effective therapy for multiple conditions and both the technology and implant techniques have evolved over more than two decades. Understanding of the ideal conditions for testing and administration of the therapy continue to progress as well, though considerable controversy still exists. This review seeks to clarify the current knowledge and opinion surrounding types of neuromodulation testing, what constitutes an optimized lead and best practices for maximizing therapeutic success. Recent findings There are distinct advantages and disadvantages to each method of sacral neuromodulation testing that should be individualized to each patient. While motor response during lead implantation may be more reliable and even necessary, an approach which balances both motor and sensory data may be advantageous. Optimized lead placement, though not conclusively proven to offer definite advantages, remains a laudable goal for most implantations. Sacral neuromodulation remains an important therapy for patients with pelvic voiding and elimination dysfunction. Important considerations including office-based or staged testing, motor or sensory prioritization, and the importance of lead optimization remain debatable. However, there remain important lessons that can influence the likelihood of successful therapy. Although there is still work to be done, we are continuing to strive for improvement in patient outcomes as a result of optimized lead placement in sacral neuromodulation.
引用
收藏
页码:74 / 79
页数:6
相关论文
共 36 条
[11]   A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation [J].
Everaert, K ;
Kerckhaert, W ;
Caluwaerts, H ;
Audenaert, M ;
Vereecke, H ;
De Cuypere, G ;
Boelaert, A ;
Van den Hombergh, U ;
Oosterlinck, W .
EUROPEAN UROLOGY, 2004, 45 (05) :649-654
[12]   Intraoperative Tips and Tricks for Successful Sacral Neuromodulation [J].
Ghamarian, Peter P. ;
Moskowitz, Dena .
CURRENT BLADDER DYSFUNCTION REPORTS, 2019, 14 (03) :191-196
[13]   Real-Time Changes in Brain Activity during Sacral Neuromodulation for Overactive Bladder [J].
Gill, Bradley C. ;
Pizarro-Berdichevsky, Javier ;
Bhattacharyya, Pallab K. ;
Brink, Thaddeus S. ;
Marks, Brian K. ;
Quirouet, Adrienne ;
Vasavada, Sandip P. ;
Jonesk, Stephen E. ;
Goldmank, Howard B. .
JOURNAL OF UROLOGY, 2017, 198 (06) :1380-1386
[14]   Number of active electrodes at time of staged tined lead interstim implant does not impact clinical outcomes [J].
Gilleran, Jason P. ;
Killinger, Kim ;
Boura, Judith ;
Peters, Kenneth M. .
NEUROUROLOGY AND URODYNAMICS, 2016, 35 (05) :625-629
[15]   International continence society best practice statement for use of sacral neuromodulation [J].
Goldman, Howard B. ;
Lloyd, Jessica C. ;
Noblett, Karen L. ;
Carey, Marcus P. ;
Castano-Botero, Juan Carlos ;
Gajewski, Jerzy B. ;
Lehur, Paul A. ;
Hassouna, Magdy M. ;
Matzel, Klaus E. ;
Paquette, Ian M. ;
de Wachter, Stefan G. ;
Ehlert, Michael J. ;
Chartier-Kastler, Emmanuel ;
Siegel, Steven W. .
NEUROUROLOGY AND URODYNAMICS, 2018, 37 (05) :1821-1822
[16]  
Gurtner K, 2020, NEUROUROL URODYNAM, V39, pS145
[17]   Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome? [J].
Jairam, Ranjana ;
Marcelissen, Tom ;
van Koeveringe, Gommert ;
van Kerrebroeck, Philip .
NEUROMODULATION, 2017, 20 (08) :830-835
[18]   Comparison of Motor and Sensory Response of InterStim® for Overactive Bladder Syndrome [J].
Lee, Jennifer ;
Osann, Kathryn ;
Noblett, Karen .
FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2013, 19 (06) :317-321
[19]   PNE Versus 1st Stage Tined Lead Procedure: A Direct Comparison to Select the Most Sensitive Test Method to Identify Patients Suitable for Sacral Neuromodulation Therapy [J].
Leong, Randall K. ;
De Wachter, Stefan G. G. ;
Nieman, F. H. M. ;
de Bie, Rob A. ;
van Kerrebroeck, Philip E. V. .
NEUROUROLOGY AND URODYNAMICS, 2011, 30 (07) :1249-1252
[20]   Sacral Neuromodulation in Urological Practice [J].
Liberman, Daniel ;
Ehlert, Michael J. ;
Siegel, Steven W. .
UROLOGY, 2017, 99 :14-22